FibroGen Stock (NASDAQ: FGEN) stock price, news, charts, stock research, profile.
Open | $0.37 |
Close | - |
Volume / Avg. | 320.23K / 2.19M |
Day Range | $0.36 - $0.38 |
52 Wk Range | 0.33 - 2.93 |
Market Cap | $37.67M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 6.01% |
Days to Cover | 4.7 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of FibroGen (NASDAQ:FGEN) through any online brokerage.
Other companies in FibroGen’s space includes: Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX) and Gain Therapeutics (NASDAQ:GANX).
FibroGen has a consensus price target of $10.00.
The stock price for FibroGen (NASDAQ: FGEN) is $0.3752 last updated September 24, 2024 at 2:09 PM EDT.
There are no upcoming dividends for FibroGen.
FibroGen’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for FibroGen.
FibroGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.